Literature DB >> 7448344

Dose-dependent disposition of oral propranolol in normal subjects.

J J Mackichan, D R Pyszczynski, W J Jusko.   

Abstract

The pharmacokinetics and relative systemic availability or oral propranolol were studied in three healthy volunteers following administration of 10, 40, and 80 mg of propranolol hydrochloride. Plasma concentrations of propranolol were determined using a sensitive and specific fluorometric high pressure liquid chromatographic technique. In the dosage range studied, the amount of propranolol reaching the systemic circulation increased with dose, while half-lives remained unchanged. The apparent 'threshold dose' for propranolol was much smaller than previously reported, and its contribution to the observed dose-dependent availability is doubtful. Apparent intrinsic clearance values were shown to decrease with increase in dose, with a true maximal intrinsic clearance of 5.4 l kg-1 h-1. These data suggest the saturation of a low capacity enzyme system in the liver and are consistent with theoretical characteristics of a drug that is extensively metabolized during its first pass through the liver.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7448344     DOI: 10.1002/bdd.2510010403

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  7 in total

1.  Possible role of metabolite in flosequinan-related mortality.

Authors:  F Kamali; C Edwards
Journal:  Clin Pharmacokinet       Date:  1995-12       Impact factor: 6.447

2.  Relationships among timolol doses, plasma concentrations and beta-adrenoceptor blocking activity.

Authors:  R K Ferguson; P H Vlasses; J R Koplin; G I Holmes; P Huber; J Demetriades; W B Abrams
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335

3.  Effects of age and smoking on the pharmacokinetics of pindolol and propranolol.

Authors:  G Hitzenberger; P Fitscha; T Beveridge; E Nüesch; W Pacha
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

4.  Bioavailability of diclofenac potassium at low doses.

Authors:  Burkhard Hinz; Julia Chevts; Bertold Renner; Henrike Wuttke; Thomas Rau; Andreas Schmidt; Istvan Szelenyi; Kay Brune; Ulrike Werner
Journal:  Br J Clin Pharmacol       Date:  2005-01       Impact factor: 4.335

Review 5.  Pharmacokinetic considerations in clinical toxicology: clinical applications.

Authors:  Darren M Roberts; Nick A Buckley
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

6.  Influence of smoking and gender on the disposition kinetics of metoprolol.

Authors:  L J Schaaf; S C Campbell; M B Mayersohn; T Vagedes; D G Perrier
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

7.  Propranolol pharmacokinetics in infants treated for Infantile Hemangiomas requiring systemic therapy: Modeling and dosing regimen recommendations.

Authors:  Laurence Del Frari; Christine Léauté-Labrèze; Laurent Guibaud; Sébastien Barbarot; Jean-Philippe Lacour; Christine Chaumont; Alain Delarue; Jean-Jacques Voisard; Valérie Brunner
Journal:  Pharmacol Res Perspect       Date:  2018-04-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.